Mirae Asset Global ETFs Holdings’s Rocket Pharmaceuticals RCKT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$522K	Buy	152,631 +47,037	+45%	+$156K	﹤0.01%	1986
2026 Q1	$377K	Buy	105,594 +12,799	+14%	+$50.9K	﹤0.01%	2030
2025 Q4	$326K	Sell	92,795 -12,124	-12%	-$41.5K	﹤0.01%	2114
2025 Q3	$342K	Sell	104,919 -7,463	-7%	-$23.5K	﹤0.01%	2043
2025 Q2	$275K	Sell	112,382 -65,732	-37%	-$333K	﹤0.01%	2115
2025 Q1	$1.19M	Buy	178,114 +566	+0.3%	+$5.59K	﹤0.01%	1406
2024 Q4	$2.23M	Buy	177,548 +3,985	+2%	+$60K	﹤0.01%	1076
2024 Q3	$3.21M	Sell	173,563 -25,208	-13%	-$516K	0.01%	911
2024 Q2	$4.28M	Buy	+198,771	New	+$4.57M	0.01%	799

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RCKT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Rocket Pharmaceuticals (RCKT) stake by 45% in Q2 2026, buying an estimated $156K and bringing the position to 152,631 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Mirae Asset Global ETFs Holdings first reported a position in RCKT in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.28M in Q2 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Mirae Asset Global ETFs Holdings held 152,631 shares of Rocket Pharmaceuticals worth $522K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 47,037 Rocket Pharmaceuticals shares in Q2 2026, an estimated $156K.
Rocket Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1986 holding.
Mirae Asset Global ETFs Holdings first reported a position in Rocket Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Rocket Pharmaceuticals position peaked at $4.28M in Q2 2024.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.